Effect of drug reminder packaging on medication adherence: A systematic review revealing research gaps

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Boeni, Fabienne ^a   Spinatsch, Esther ^a   Suter, Katja ^b   Hersberger, Kurt E ^a   Arnet, Isabelle ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Blister pouch; Dose dispensing service; Drug reminder packaging; Medication adherence; Multicompartment adherence aid; multidrug punch card; Patient compliance; Pillbox; Polypharmacy

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL RESEARCH; EVIDENCE BASED PRACTICE; HUMAN; INFORMATION PROCESSING; MEDICATION COMPLIANCE; META ANALYSIS; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; DRUG PACKAGING; PSYCHOLOGICAL ASPECT; REMINDER SYSTEM; REVIEW; STATISTICS;

DRUG PACKAGING; HUMANS; MEDICATION ADHERENCE; REMINDER SYSTEMS;

EID: 84907074754     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-29     Document Type: Article

References (74)

1. Adherence to long-term therapies - Evidence for action. [http://www.who.int/chp/knowledge/publications/adherence:full_report.pdf].
2. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004, 42:200-209. 10.1097/01.mlr.0000114908.90348.f9, 15076819.
3. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998, 49:196-201.
4. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497. 10.1056/NEJMra050100, 16079372.
5. Wroe AL. Intentional and unintentional nonadherence: a study of decision making. J Behav Med 2002, 25:355-372. 10.1023/A:1015866415552, 12136497.
6. Cutler DM, Long G, Berndt ER, Royer J, Fournier A-A, Sasser A, Cremieux P. The value of antihypertensive drugs: a perspective on medical innovation. Health Aff (Millwood) 2007, 26:97-110. 10.1377/hlthaff.26.1.97, 17211019.
7. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, Masoudi FA, Rumsfeld JS. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 2008, 155:772-779. 10.1016/j.ahj.2007.12.011, 18371492.
8. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 1836-1841, 2006:166.
9. Zed PJ, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, Brubacher JR, Wilbur K, Wiens MO, Samoy LJ, Lacaria K, Purssell RA. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. Can Med Assoc J 2008, 178:1563-1569.
10. Hughes DA, Bagust A, Haycox A, Walley T. The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ 2001, 10:601-615. 10.1002/hec.609, 11747044.
11. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood) 2011, 30:91-99. 10.1377/hlthaff.2009.1087, 21209444.
12. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008, 168:1890-1896.
13. Mennini FS, Marcellusi A, von der Schulenburg JM, Gray A, Levy P, Sciattella P, Soro M, Staffiero G, Zeidler J, Maggioni A, Schmieder RE. Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur J Health Econ 2014, Epub ahead of print.
14. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008, CD000011.
15. Cramer JA. Enhancing patient compliance in the elderly. Role of packaging aids and monitoring. Drugs Aging 1998, 12:7-15. 10.2165/00002512-199812010-00002, 9467683.
16. Gould ON, Todd L, Irvine-Meek J. Adherence devices in a community sample: how are pillboxes used?. Can Pharm J 2009, 142:28-35.
17. Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence 2013, 7:675-682. 3711878, 23874088.
18. Mahtani KR, Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev 2011, CD005025.
19. Connor J, Rafter N, Rodgers A. Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ 2004, 82:935-939. 2623099, 15654408.
20. Zedler BK, Kakad P, Colilla S, Murrelle L, Shah NR. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Clin Ther 2011, 33:62-73. 10.1016/j.clinthera.2011.02.003, 21397775.
21. Bragge P, Clavisi O, Turner T, Tavender E, Collie A, Gruen RL. The Global Evidence Mapping Initiative: scoping research in broad topic areas. BMC Med Res Methodol 2011, 11:92. 10.1186/1471-2288-11-92, 3141802, 21682870.
22. Schmucker C, Motschall E, Antes G, Meerpohl JJ. Methods of evidence mapping: a systematic review. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013, 56:1390-1397. 10.1007/s00103-013-1818-y, 23978984.
23. Hersberger KE, Boeni F, Arnet I. Dose-dispensing service as an intervention to improve adherence to polymedication. Expert Rev Clin Pharmacol 2013, 6:413-421. 10.1586/17512433.2013.811829, 23927669.
24. Qualitative assessment tool for quantitative studies. [http://www.ephpp.ca/tools.html].
25. Thomas BH, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 2004, 1:176-184. 10.1111/j.1524-475X.2004.04006.x, 17163895.
26. Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract 2012, 18:12-18. 10.1111/j.1365-2753.2010.01516.x, 20698919.
27. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008, 148:295-309. 10.7326/0003-4819-148-4-200802190-00008, 18283207.
28. The Cochrane Handbook for systematic reviews of interventions. [http://handbook.cochrane.org/].
29. Kozma CM, Reeder CE, Schulz RM. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 1993, 15:1121-1132.
30. Ascione FJ, Shimp LA. The effectiveness of four education strategies in the elderly. Drug Intell Clin Pharm 1984, 18:926-931.
31. Azrin NH, Teichner G. Evaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients. Behav Res Ther 1998, 36:849-861. 10.1016/S0005-7967(98)00036-9, 9701860.
32. Becker LA, Glanz K, Sobel E, Mossey J, Zinn S, Andrews Knott K. A randomized trial of special packaging of antihypertensive medications. J Fam Pract 1985, 22:357-361.
33. Binstock ML, Franklin KL. A comparison of compliance techniques on the control of high blood pressure. Am J Hypertens 1988, 1:192S-194S. 10.1093/ajh/1.3.192S, 3415798.
34. Crome P, Akehurst M, Keet J. Drug compliance in elderly hospital in-patients. Trial of the Dosett box. Practitioner 1980, 224:782-785.
35. Crome P, Curl B, Boswell M, Corless D, Lewis RR. Assessment of a new calendar pack - the 'C-Pak'. Age Ageing 1982, 11:275-279. 10.1093/ageing/11.4.275, 7180732.
36. Eshelman FN, Fitzloff J. Effect of packaging on patient compliance with an antihypertensive medication. Curr Ther Res Clin Exp 1976, 20:215-219.
37. Fairley CK, Levy R, Rayner CR, Allardice K, Costello K, Thomas C, McArthur C, Kong D, Mijch A, . Melbourne Adherence Group Randomized trial of an adherence programme for clients with HIV. Int J STD AIDS 2003, 14:805-809. 10.1258/095646203322556129, 14678587, Melbourne Adherence Group.
38. Henry A, Batey RG. Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the HelP Study. Am J Gastroenterol 1999, 94:811-815. 10.1111/j.1572-0241.1999.00856.x, 10086671.
39. Huang H-Y, Maguire MG, Miller ER, Appel LJ. Impact of pill organizers and blister packs on adherence to pill taking in two vitamin supplementation trials. Am J Epidemiol 2000, 152:780-787. 10.1093/aje/152.8.780, 11052557.
40. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006, 296:2563-2571. 10.1001/jama.296.21.joc60162, 17101639.
41. Lee M, Kemp JA, Canning A, Egan C, Tataronis G, Farraye FA. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med 1999, 159:2312-2316.
42. MacDonald ET, MacDonald JB, Phoenix M. Improving drug compliance after hospital discharge. Br Med J 1977, 2:618-621. 10.1136/bmj.2.6087.618, 1631539, 902005.
43. Maier C, Mustapic D, Schuster E, Luger A, Eher R. Effect of a pocket-size tablet-dispensing device on glycaemic control in Type 2 diabetic patients. Diabet Med 2006, 23:40-45. 10.1111/j.1464-5491.2005.01721.x, 16409564.
44. McPherson-Baker S, Malow RM, Penedo F, Jones DL, Schneiderman N, Klimas NG. Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care 2000, 12:399-404. 10.1080/09540120050123792, 11091772.
45. Miaskowski C, Dodd M, West C, Schumacher K, Paul SM, Tripathy D, Koo P. Randomized clinical trial of the effectiveness of a self-care intervention to improve cancer pain management. J Clin Oncol 2004, 22:1713-1720. 10.1200/JCO.2004.06.140, 15117994.
46. Murray MD, Birt JA, Manatunga AK, Darnell JC. Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging. Ann Pharmacother 1993, 27:616-621.
47. Nochowitz B, Shapiro NL, Nutescu EA, Cavallari LH. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population. Ann Pharmacother 2009, 43:1165-1172. 10.1345/aph.1L707, 19549747.
48. Park DC, Morrell RW, Frieske D, Kincaid D. Medication adherence behaviors in older adults: effects of external cognitive supports. Psychol Aging 1992, 7:252-256.
49. Peterson GM, McLean S, Millingen KS. A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia 1984, 25:412-417. 10.1111/j.1528-1157.1984.tb03436.x, 6430689.
50. Rheder TL, McCoy LK, Blackwell B, Whitehead W, Robinson A. Improving medication compliance by counseling and special prescription container. Am J Hosp Pharm 1980, 37:378-385.
51. Schneider PJ, Murphy JE, Pedersen CA. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc 2008, 48:58-63.
52. Simmons D, Upjohn M, Gamble GD. Can medication packaging improve glycemic control and blood pressure in type 2 diabetes? Results from a randomized controlled trial. Diabetes Care 2000, 23:153-156. 10.2337/diacare.23.2.153, 10868823.
53. Skaer TL, Sclar DA, Markowski DJ, Won JK. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures - a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther 1993, 18:295-299. 10.1111/j.1365-2710.1993.tb00591.x, 8227238.
54. Skaer TL, Sclar DA, Markowski DJ, Won JK. Effect of value-added utilities on prescription refill compliance and health care expenditures for hypertension. J Hum Hypertens 1993, 7:515-518.
55. Solomon MZ, DeJong W. The impact of a clinic-based educational videotape on knowledge and treatment behavior of men with gonorrhea. Sex Transm Dis 1988, 15:127-132. 10.1097/00007435-198807000-00001, 2465581.
56. Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow FC. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull 2009, 37:727-736. 3122282, 19933540.
57. Ware GJ, Holford NH, Davison JG, Harris RG. Unit dose calendar packaging and elderly patient compliance. N Z Med J 1991, 104:495-497.
58. Winland-Brown JE, Valiante J. Effectiveness of different medication management approaches on elders' medication adherence. Outcomes Manag Nurs Pract 2000, 4:172-176.
59. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996, 276:637-639. 10.1001/jama.1996.03540080059030, 8773637.
60. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996, 348:383-386. 10.1016/S0140-6736(96)01073-2, 8709739.
61. Chan A-W, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 2005, 365:1159-1162. 10.1016/S0140-6736(05)71879-1, 15794971.
62. Hopewell S, Dutton S, Yu L-M, Chan A-W, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ 2010, 340.
63. Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, Dias S, Schulz KF, Plint AC, Moher D. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012, MR000030.
64. Huwiler-Muntener K, Juni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 2002, 287:2801-2804. 10.1001/jama.287.21.2801, 12038917.
65. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews?. BMJ 2008, 336:1472-1474. 10.1136/bmj.39590.732037.47, 2440840, 18583680.
66. Dopson S, Locock L, Chambers D, Gabbay J. Implementation of evidence-based medicine: evaluation of the Promoting Action on Clinical Effectiveness programme. J Health Serv Res Policy 2001, 6:23-31. 10.1258/1355819011927161, 11219356.
67. Ostrop NJ, Gill MJ. Antiretroviral medication adherence and persistence with respect to adherence tool usage. AIDS Patient Care STDS 2000, 14:351-358. 10.1089/108729100413220, 10935052.
68. Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis 2007, 45:908-915. 10.1086/521250, 2442040, 17806060.
69. Wilson S, Delaney BC, Roalfe A, Roberts L, Redman V, Wearn AM, Hobbs FD. Randomised controlled trials in primary care: case study. BMJ 2000, 321:24-27. 27422, 10875830.
70. Moser M. Randomized clinical trials: alternatives to conventional randomization. Am J Emerg Med 1986, 4:276-285. 10.1016/0735-6757(86)90086-0, 3964374.
71. Atkin PA, Finnegan TP, Ogle SJ, Shenfield GM. Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing 1994, 23:113-116. 10.1093/ageing/23.2.113, 8023717.
72. Rivers PH. Compliance aids - do they work?. Drugs Aging 1992, 2:103-111. 10.2165/00002512-199202020-00004, 1596593.
73. Levings B, Szep S, Helps S. Towards the safer use of dosettes. J Qual Clin Pract 1999, 19:69-72. 10.1046/j.1440-1762.1999.00303.x, 10096730.
74. Nunney J, Raynor DK. Mind the gap: how compliance aids increase distance between patients and their medicines. Int J Pharm Pract 2001, 9(suppl):R46.